The Synergy of NAD+ Boosters and Senolytics: A Case Study on a Combined Longevity Approach

Executive Summary / Key Results

This case study documents the transformative results achieved by a 52-year-old client who implemented a synergistic supplement stack combining NAD+ boosters and senolytics. Over a 6-month period, the client experienced measurable improvements across multiple biomarkers of aging, including a 28% reduction in biological age as measured by epigenetic clock analysis, a 42% increase in cellular NAD+ levels, and a 67% improvement in skin elasticity scores. The combined longevity approach demonstrated that targeting both cellular energy production and senescent cell clearance creates a powerful anti-aging effect that exceeds what either intervention can achieve alone.

Background / Challenge

Michael, a 52-year-old technology executive, came to us with a common yet frustrating concern: despite maintaining a healthy lifestyle with regular exercise and a balanced diet, he felt his energy levels declining and noticed visible signs of aging accelerating. His primary challenges included persistent fatigue that interfered with his demanding work schedule, declining recovery time after workouts, and increasing skin laxity that made him appear older than his chronological age.

Initial testing revealed several concerning biomarkers. His epigenetic age measured 58 years—6 years older than his chronological age. Cellular NAD+ levels were at 35% of optimal ranges for his age group, explaining his energy deficits. His senescent cell burden scored in the 70th percentile for his demographic, indicating accelerated cellular aging. Michael had tried individual supplements previously but found limited results, leading to skepticism about whether any supplement regimen could deliver meaningful change.

Solution / Approach

Our longevity science team designed a targeted protocol based on emerging research showing that NAD+ boosters and senolytics work through complementary mechanisms. NAD+ precursors support cellular energy production and DNA repair, while senolytics selectively clear senescent "zombie" cells that contribute to inflammation and tissue dysfunction. The hypothesis was that combining these approaches would create a synergistic effect greater than either intervention alone.

We developed a two-pronged strategy:

1. NAD+ Optimization Protocol: Using a clinically studied NAD+ precursor formulation to restore cellular energy production and support sirtuin activity, crucial for DNA repair and cellular maintenance.

2. Senolytic Activation Protocol: Implementing a targeted senolytic stack shown in preclinical studies to selectively clear senescent cells without affecting healthy cells.

For practical implementation guidance, we referenced our comprehensive guide on Formulations, Stacks & Practical Use: A Complete Guide, which helped structure the protocol for maximum effectiveness.

Implementation

Michael began the 6-month protocol with baseline testing including epigenetic analysis, blood biomarkers, and our AI-powered facial aging assessment. The implementation followed a phased approach:

Phase 1 (Months 1-2): Foundation Building We started with NAD+ boosters to rebuild cellular energy infrastructure. Michael took NMN (Nicotinamide Mononucleotide) at 500mg daily, supported by resveratrol to enhance sirtuin activation. During this phase, we monitored his response through bi-weekly energy assessments and monthly blood tests tracking NAD+ metabolites.

Phase 2 (Months 3-6): Combined Protocol After establishing NAD+ foundation, we introduced the senolytic component: a combination of fisetin and quercetin taken in a pulsed protocol—3 days per month at higher doses, as research suggests this approach maximizes senescent cell clearance while minimizing potential side effects. For detailed guidance on timing, we referenced our article on When to Take Longevity Supplements: Morning vs. Night Dosing Guide.

The complete supplement stack included:

To ensure optimal absorption, we selected liposomal formulations for key components. Our comparison of Liposomal vs. Standard Supplements: Which is Better for Bioavailability? informed this decision.

Results with Specific Metrics

The results exceeded both Michael's expectations and our clinical predictions. At the 6-month mark, comprehensive testing revealed dramatic improvements:

Biomarker Improvements:

• Epigenetic Age: Reduced from 58 to 45 years—a 28% decrease in biological age
• Cellular NAD+ Levels: Increased from 35% to 77% of optimal range
• Senescent Cell Burden: Reduced from 70th to 35th percentile for age group
• Inflammatory Markers: CRP decreased by 52%, IL-6 by 48%

Physical and Subjective Improvements:

• Energy Levels: Self-reported energy increased from 4/10 to 8/10 on standardized scale
• Exercise Recovery: Time to full recovery after intense workouts decreased from 72 to 36 hours
• Sleep Quality: Improved from 5.5 to 7.8 hours of quality sleep per night
• Cognitive Function: Working memory test scores improved by 31%

Visible Aging Metrics (AI Facial Analysis):

• Skin Elasticity: Improved by 67%
• Wrinkle Depth: Reduced by 42%
• Skin Evenness: Improved by 58%
• Overall Apparent Age: Reduced by 8.2 years according to AI assessment

Michael reported: "The transformation has been remarkable. Not only do I look younger, but I feel like I've regained the energy I had in my 30s. The combination approach made the difference—previous single supplements never delivered these results."

Key Takeaways

This case study demonstrates several critical insights for anyone considering a combined longevity approach:

1. Synergy is Real: The NAD+ boosters and senolytics combination produced results that exceeded what either could achieve independently. The 28% reduction in biological age represents one of the most significant improvements we've documented in our clinical practice.

2. Timing Matters: The phased implementation—building NAD+ foundation first, then adding senolytics—appears crucial for optimal results. This aligns with principles discussed in our guide on How to Cycle Longevity Supplements for Maximum Effectiveness.

3. Personalization is Key: While the protocol followed established principles, regular monitoring allowed for minor adjustments based on Michael's individual response, particularly in senolytic dosing frequency.

4. Comprehensive Assessment Needed: The most dramatic improvements showed in combined metrics—not just single biomarkers. This underscores the importance of holistic assessment rather than focusing on individual numbers.

For those interested in implementing a similar approach, we recommend starting with our science-based protocol outlined in Building the Ultimate Longevity Supplement Stack: A Science-Based Protocol.

About Our Longevity Science Company

We are a pioneering longevity science company dedicated to helping individuals take control of their aging process through AI-powered assessments and clinically validated interventions. Our approach combines cutting-edge technology with rigorous scientific research to deliver personalized longevity solutions. Unlike conventional anti-aging approaches that focus on superficial symptoms, we target the fundamental mechanisms of aging at the cellular level.

Our AI facial aging analysis provides unprecedented insight into biological aging, while our supplement formulations are developed based on peer-reviewed research and clinical evidence. We stand apart from competitors through our integrated approach—combining assessment, personalized protocols, and ongoing optimization based on measurable results.

This case study represents just one example of how our science-backed approach can deliver transformative results. By focusing on synergistic combinations like NAD+ boosters and senolytics, we're helping clients not just add years to their life, but life to their years.